Explore All Access
Check if your research matches the topics covered in Cardiovascular Therapeutics?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Cardiovascular Therapeutics : Impact Factor & More
eISSN: 1755-5922pISSN: 1755-5914
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Cardiovascular Therapeutics Key Metrics
CiteScore 
4.6
H-Index
52
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.87
Time to Accept
5
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months14%
4 to 6 months36%
7 to 9 months43%
Above 9 months7%
Did you find this useful?
Topics Covered on Cardiovascular Therapeutics
Blood pressure
Genetic model
Myocardial infarction
Odds ratio
Atrial fibrillation
Heart rate
Key genes
Heart failure
Red yeast rice
Quality of life
Placebo
Clopidogrel
Pulmonary hemodynamics
Warfarin
Hub genes
Percutaneous coronary intervention
Nutraceutical
Catheter ablation
Heat shock protein
Rosuvastatin
Cardiovascular Therapeutics Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | WILEY-HINDAWI |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2000 |
| Publication Time | 19 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Cardiovascular Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cardiovascular Therapeutics
Transcatheter Embolization in Congenital Cardiovascular Malformations—Variable Use of Vascular Plugs
- 29 May 2024
- Cardiovascular Therapeutics
Invasive Hemodynamic Changes Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- 27 May 2024
- Cardiovascular Therapeutics
Attenuating Atherosclerosis through Inhibition of the NF-κB/NLRP3/IL-1β Pathway-Mediated Pyroptosis in Vascular Smooth Muscle Cells (VSMCs)
- 25 Mar 2024
- Cardiovascular Therapeutics
Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure.
- 12 Mar 2024
- Cardiovascular therapeutics
DUSP22 Ameliorates Endothelial-to-Mesenchymal Transition in HUVECs through Smad2/3 and MAPK Signaling Pathways.
- 8 Mar 2024
- Cardiovascular therapeutics
Major Limitations of Cardiovascular Risk Scores.
- 28 Feb 2024
- Cardiovascular therapeutics
Transcatheter Embolization in Congenital Cardiovascular Malformations—Variable Use of Vascular Plugs
- 29 May 2024
- Cardiovascular Therapeutics
Invasive Hemodynamic Changes Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- 27 May 2024
- Cardiovascular Therapeutics
Attenuating Atherosclerosis through Inhibition of the NF-κB/NLRP3/IL-1β Pathway-Mediated Pyroptosis in Vascular Smooth Muscle Cells (VSMCs)
- 25 Mar 2024
- Cardiovascular Therapeutics
Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure.
- 12 Mar 2024
- Cardiovascular therapeutics
DUSP22 Ameliorates Endothelial-to-Mesenchymal Transition in HUVECs through Smad2/3 and MAPK Signaling Pathways.
- 8 Mar 2024
- Cardiovascular therapeutics
Major Limitations of Cardiovascular Risk Scores.
- 28 Feb 2024
- Cardiovascular therapeutics
Compare Similar Journals with Cardiovascular Therapeutics
Select Journals to Compare with Cardiovascular Therapeutics
Total journals - 10
You can select up to 3 Journals at a time
European Heart Journal
Publisher: OXFORD UNIV PRESS
Circulation
Publisher: LIPPINCOTT WILLIAMS & WILKINS
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Scientific Reports
Publisher: NATURE PORTFOLIO
Journal of the American Heart Association
Publisher: WILEY
Journal of the American College of Cardiology
Publisher: ELSEVIER SCIENCE INC
International Journal of Cardiology
Publisher: ELSEVIER IRELAND LTD
Medicine
Publisher: Elsevier
Frontiers in Cardiovascular Medicine
Publisher: FRONTIERS MEDIA SA
BMC Cardiovascular Disorders
Publisher: BMC
0 Journals Selected to compare with
Cardiovascular Therapeutics
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Cardiovascular Therapeutics
How long has Cardiovascular Therapeutics been actively publishing? 
Cardiovascular Therapeutics has been in operation since 2008 till date.
What is the publishing frequency of Cardiovascular Therapeutics?
Cardiovascular Therapeutics published with a Continuous publication frequency.
How many articles did Cardiovascular Therapeutics publish last year?
In 2023, Cardiovascular Therapeutics publsihed 34 articles.
What is the eISSN & pISSN for Cardiovascular Therapeutics?
For Cardiovascular Therapeutics, eISSN is 1755-5922 and pISSN is 1755-5914.
What is Citescore for Cardiovascular Therapeutics?
Citescore for Cardiovascular Therapeutics is 4.6.
What is the H Index for Cardiovascular Therapeutics ?
H Index for Cardiovascular Therapeutics is 52.
What is SNIP score for Cardiovascular Therapeutics?
SNIP score for Cardiovascular Therapeutics is 0.87.
What is the SJR for Cardiovascular Therapeutics?
SJR for Cardiovascular Therapeutics is Q2.
Who is the publisher of Cardiovascular Therapeutics?
WILEY-HINDAWI is the publisher of Cardiovascular Therapeutics.
